Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Highlight
  • Published:

Therapy

Ustekinumab therapeutic effects—more than skin deep

Nature Reviews Rheumatology volume 9, page 445 (2013)Cite this article

Subjects

“Ustekinumab performed better than placebo in the treatment of patients with active psoriatic arthritis,” says Iain McInnes (University of Glasgow, UK), when describing the 1 year results of the PSUMMIT1 trail, now published in The Lancet. “Improvements were seen in joints, skin and in the enthesial components of the disease.”

Significantly more patients receiving ustekinumab achieved an ACR20 response...

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

ORIGINAL RESEARCH PAPER

  1. McInnes, I. B. et al. Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial. Lancet doi:10.1016/S0140-6736(13)60594-2

Download references

Authors
  1. Jenny Buckland
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Buckland, J. Ustekinumab therapeutic effects—more than skin deep. Nat Rev Rheumatol 9, 445 (2013). https://doi.org/10.1038/nrrheum.2013.106

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/nrrheum.2013.106

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing